A phase I‐ II II clinical trial of the anti‐ CD CD 74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach A patient based approach

著录项

• 来源
  《British Journal of Haematology》 |2018年第1期|共4页
• 作者

  Haran Michal; Mirkin Vita; Braester Andrei; Harpaz Nurith; Shevetz Olga; Shtreiter Marina; Greenberg Shulamit; Mordich Orly; Amram Orna; Binsky‐Ehrenreich Inbal; Marom Ayelet; Shachar Idit; Herishanu Yair; Ruchlemer Rosa; Berrebi Alain; Valinsky Liora; Shtalrid Mordechai; Shvidel Lev;

  展开▼
• 作者单位

  Haematology InstituteKaplan Medical CentreRehovot Israel;

  Haematology InstituteKaplan Medical CentreRehovot Israel;

  Haematology InstituteGalilee Medical CentreNahariya Israel;

  Haematology InstituteKaplan Medical CentreRehovot Israel;

  Haematology InstituteKaplan Medical CentreRehovot Israel;

  Haematology InstituteKaplan Medical CentreRehovot Israel;

  Haematology InstituteKaplan Medical CentreRehovot Israel;

  Haematology InstituteKaplan Medical CentreRehovot Israel;

  Haematology InstituteKaplan Medical CentreRehovot Israel;

  Department of ImmunologyWeizmann Institute of ScienceRehovot Israel;

  Department of ImmunologyWeizmann Institute of ScienceRehovot Israel;

  Department of ImmunologyWeizmann Institute of ScienceRehovot Israel;

  Department of HaematologyTel‐Aviv ?UniversityTel Aviv Israel;

  Department of HaematologyShaare ZedekJerusalem Israel;

  Haematology InstituteKaplan Medical CentreRehovot Israel;

  Haematology InstituteKaplan Medical CentreRehovot Israel;

  Haematology InstituteKaplan Medical CentreRehovot Israel;

  Haematology InstituteKaplan Medical CentreRehovot Israel;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词

  chronic lymphocytic leukaemia; elderly patients; milatuzumab; Phase I clinical trial; performance status;

  机译：慢性淋巴细胞白血病;老年患者;MILATUZUMAB;I阶段临床试验;性能状态;